Guy N. L. Jameson
MacDiarmid Institute for Advanced Materials and Nanotechnology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Guy N. L. Jameson.
Proceedings of the National Academy of Sciences of the United States of America | 2003
Wing-Hang Tong; Guy N. L. Jameson; Boi Hanh Huynh; Tracey A. Rouault
Iron–sulfur (Fe–S) clusters serve as cofactors in many proteins that have important redox, catalytic, and regulatory functions. In bacteria, biogenesis of Fe–S clusters is mediated by multiple gene products encoded by the isc and nif operons. In particular, genetic and biochemical studies suggest that IscU, Nfu, and IscA function as scaffold proteins for assembly and delivery of rudimentary Fe–S clusters to target proteins. Here we report the characterization of human Nfu. A combination of biochemical and spectroscopic techniques, including UV-visible absorption and 57Fe Mössbauer spectroscopies, have been used to investigate the ability of purified human Nfu to assemble Fe–S clusters. The results suggest that Nfu can assemble approximately one labile [4Fe–4S] cluster per two Nfu monomers, and support the proposal that Nfu is an alternative scaffold protein for assembly of clusters that are subsequently used for maturation of targeted Fe–S proteins. Analyses of genomic DNA, transcripts, and translation products indicate that alternative splicing of a common pre-mRNA results in synthesis of two Nfu isoforms with distinct subcellular localizations. Isoform I is localized in the mitochondria, whereas isoform II is present in the cytosol and the nucleus. These results, together with previous reports of subcellular distributions of isoforms of human IscS and IscU in mitochondria, cytosol, and nucleus suggest that the Fe–S cluster assembly machineries are compartmentalized in higher eukaryotes.
Journal of Biological Chemistry | 2011
Flavia C. Meotti; Guy N. L. Jameson; Rufus Turner; D. Tim Harwood; Samantha Stockwell; Martin D. Rees; Shane R. Thomas; Anthony J. Kettle
Urate and myeloperoxidase (MPO) are associated with adverse outcomes in cardiovascular disease. In this study, we assessed whether urate is a likely physiological substrate for MPO and if the products of their interaction have the potential to exacerbate inflammation. Urate was readily oxidized by MPO and hydrogen peroxide to 5-hydroxyisourate, which decayed to predominantly allantoin. The redox intermediates of MPO were reduced by urate with rate constants of 4.6 × 105 m−1 s−1 for compound I and 1.7 × 104 m−1 s−1 for compound II. Urate competed with chloride for oxidation by MPO and at hyperuricemic levels is expected to be a substantive substrate for the enzyme. Oxidation of urate promoted super-stoichiometric consumption of glutathione, which indicates that it is converted to a free radical intermediate. In combination with superoxide and hydrogen peroxide, MPO oxidized urate to a reactive hydroperoxide. This would form by addition of superoxide to the urate radical. Urate also enhanced MPO-dependent consumption of nitric oxide. In human plasma, stimulated neutrophils produced allantoin in a reaction dependent on the NADPH oxidase, MPO and superoxide. We propose that urate is a physiological substrate for MPO that is oxidized to the urate radical. The reactions of this radical with superoxide and nitric oxide provide a plausible link between urate and MPO in cardiovascular disease.
Chemical Research in Toxicology | 2009
Péter Nagy; Guy N. L. Jameson; Christine C. Winterbourn
Hypothiocyanite is a major oxidant generated by mammalian peroxidases. Although reported to react specifically with thiol groups in biological molecules, a detailed mechanistic study of this reaction has not been conducted. We have investigated the reaction of hypothiocyanous acid/hypothiocyanite with 5-thio-2-nitrobenzoic acid and with reduced glutathione by stopped-flow spectroscopy. The observed bell-shaped pH profile established that the reaction with 5-thio-2-nitrobenzoic acid proceeds via the thiolate and hypothiocyanous acid in the 2.5 < pH < 8 region. The obtained second-order rate constant of the reaction is (1.26 + or - 0.02) x 10(8) M(-1) s(-1), and the effective rate constant at pH 7.4 is (4.37 + or - 0.03) x 10(5) M(-1) s(-1). Analysis of the kinetic data, using a value of 4.38 + or - 0.01 for the pK(a) of 5-thio-2-nitrobenzoic acid thiol (measured independently by spectroscopic analysis), gave a pK(a) of 4.85 + or - 0.01 for hypothiocyanous acid at physiological salt concentration (I = 120 mM; NaCl and phosphate buffer) and 25 degrees C. A second-order rate constant of (8.0 + or - 0.5) x 10(4) M(-1) s(-1) for the reaction of hypothiocyanous acid/hypothiocyanite with reduced glutathione at pH 7.4 was determined. The glutathione data are also consistent with the reaction proceeding via the thiolate and hypothiocyanous acid. Our results demonstrate that hypothiocyanous acid/hypothiocyanite has very high reactivity with thiols and will be short-lived in the presence of physiological concentrations of glutathione and thiol proteins. As the reaction occurs strictly with the thiolate, this oxidant should selectively target proteins containing low pK(a) thiols.
Journal of Inorganic Biochemistry | 2000
Wolfgang Linert; Guy N. L. Jameson
In Parkinsons Disease the neuromelanin in the substania nigra is known to contain considerably increased amounts of iron suggesting the presence of free, unprotected iron ions during its formation. Iron(II) is known to interact with peroxide via Fentons reaction producing OH-radicals or ferryl (Fe(IV)) species. This can readily oxidize the neurotransmitter dopamine to the neurotoxic 6-hydroxydopamine (6-OHDA) which is a strong reducing agent. The produced 6-OHDA is, in turn, able to reduce and possibly release iron, as iron(II), from the iron storage protein ferritin. This cycle of events could well explain the development of Parkinsons Disease due to a continuous production of cell damaging species. The contrasting behaviour of 6-OHDA with some other important catecholamines is discussed.
Journal of Biological Chemistry | 2013
Anna L.P. Chapman; Tessa J. Mocatta; Sruti Shiva; Antonia Seidel; Brian Chen; Irada Khalilova; Martina Paumann-Page; Guy N. L. Jameson; Christine C. Winterbourn; Anthony J. Kettle
Background: Myeloperoxidase promotes oxidative stress during inflammation by producing hypochlorous acid. Results: Ceruloplasmin was a potent inhibitor of myeloperoxidase and slowed its activity in plasma from wild type mice compared with ceruloplasmin knock-out animals. Conclusion: Ceruloplasmin is a physiologically relevant inhibitor of myeloperoxidase. Significance: Ceruloplasmin will provide a protective shield against oxidant production by myeloperoxidase during inflammation. Myeloperoxidase is a neutrophil enzyme that promotes oxidative stress in numerous inflammatory pathologies. It uses hydrogen peroxide to catalyze the production of strong oxidants including chlorine bleach and free radicals. A physiological defense against the inappropriate action of this enzyme has yet to be identified. We found that myeloperoxidase oxidized 75% of the ascorbate in plasma from ceruloplasmin knock-out mice, but there was no significant loss in plasma from wild type animals. When myeloperoxidase was added to human plasma it became bound to other proteins and was reversibly inhibited. Ceruloplasmin was the predominant protein associated with myeloperoxidase. When the purified proteins were mixed, they became strongly but reversibly associated. Ceruloplasmin was a potent inhibitor of purified myeloperoxidase, inhibiting production of hypochlorous acid by 50% at 25 nm. Ceruloplasmin rapidly reduced Compound I, the FeV redox intermediate of myeloperoxidase, to Compound II, which has FeIV in its heme prosthetic groups. It also prevented the fast reduction of Compound II by tyrosine. In the presence of chloride and hydrogen peroxide, ceruloplasmin converted myeloperoxidase to Compound II and slowed its conversion back to the ferric enzyme. Collectively, our results indicate that ceruloplasmin inhibits myeloperoxidase by reducing Compound I and then trapping the enzyme as inactive Compound II. We propose that ceruloplasmin should provide a protective shield against inadvertent oxidant production by myeloperoxidase during inflammation.
Inorganic Chemistry | 2011
Jonathan A. Kitchen; Nicholas G. White; Guy N. L. Jameson; Jeffery L. Tallon; Sally Brooker
Seven diiron(II) complexes, [Fe(II)(2)(PMAT)(2)](X)(4), varying only in the anion X, have been prepared, where PMAT is 4-amino-3,5-bis{[(2-pyridylmethyl)-amino]methyl}-4H-1,2,4-triazole and X = BF(4)(-) (1), Cl(-) (2), PF(6)(-) (3), SbF(6)(-) (4), CF(3)SO(3)(-) (5), B(PhF)(4)(-) (6), and C(16)H(33)SO(3)(-) (7). Most were isolated as solvates, and the microcrystalline ([3], [4]·2H(2)O, [5]·H(2)O, and [6]·½MeCN) or powder ([2]·4H(2)O, and [7]·2H(2)O) samples obtained were studied by variable-temperature magnetic susceptibility and Mössbauer methods. A structure determination on a crystal of [2]·2MeOH·H(2)O, revealed it to be a [LS-HS] mixed low spin (LS)-high spin (HS) state dinuclear complex at 90 K, but fully high spin, [HS-HS], at 293 K. In contrast, structures of both [5]·¾IPA·H(2)O and [7]·1.6MeOH·0.4H(2)O showed them to be [HS-HS] at 90 K, whereas magnetic and Mössbauer studies on [5]·H(2)O and [7]·2H(2)O revealed a different spin state, [LS-HS], at 90 K, presumably because of the difference in solvation. None of these complexes undergo thermal spin crossover (SCO) to the fully LS form, [LS-LS]. The PF(6)(-) and SbF(6)(-) complexes, 3 and [4]·2H(2)O, appear to be a mixture of [HS-LS] and [HS-HS] at low temperature, and undergo gradual SCO to [HS-HS] on warming. The CF(3)SO(3)(-) complex [5]·H(2)O undergoes gradual, partial SCO from [HS-LS] to a mixture of [HS-LS] and [HS-HS] at T(1/2) ≈ 180 K. The B(PhF)(4)(-) and C(16)H(33)SO(3)(-) complexes, [6]·(1)/(2)MeCN and [7]·2H(2)O, are approximately [LS-HS] at all temperatures, with an onset of gradual SCO with T(1/2) > 300 K.
Chemical Communications | 2010
Jonathan A. Kitchen; Nicholas G. White; Claudio Gandolfi; Martin Albrecht; Guy N. L. Jameson; Jeffery L. Tallon; Sally Brooker
[Fe(II)(C(16)dpt)(2)(NCS)(2)].(2/3)H(2)O displays temperature-mediated spin crossover (SCO) with T((1/2)) = 290 K and the long alkyl chain substituent on the dipyridyltriazole ligand facilitates the formation of a stable Langmuir-Blodgett film at an air-water interface.
Dalton Transactions | 2011
Rosanna J. Archer; Chris S. Hawes; Guy N. L. Jameson; Vickie McKee; Boujemaa Moubaraki; Nicholas F. Chilton; Keith S. Murray; Wolfgang Schmitt; Paul E. Kruger
Reported herein are the synthesis, structural, magnetic and Mössbauer spectroscopic characterisation of a dinuclear Fe(II) triple helicate complex [Fe(2)(L)(3)](ClO(4))(4).xH(2)O (x = 1-4), 1(H(2)O), where L is a bis-bidentate imidazolimine ligand. Low temperature structural analysis (150 K) and Mössbauer spectroscopy (4.5 K) are consistent with one of the Fe(II) centres within the helicate being in the low spin (LS) state with the other being in the high-spin (HS) state resulting in a [LS:HS] species. However, Mössbauer spectroscopy (295 K) and variable temperature magnetic susceptibility measurements (4.5-300 K) reveal that 1(H(2)O) undergoes a reversible single step spin crossover at one Fe(II) centre at higher temperatures resulting in a [HS:HS] species. Indeed, the T(1/2)(SCO) values at this Fe(II) centre also vary as the degree of hydration, x, within 1(H(2)O) changes from 1 to 4 and are centred between ca. 210 K-265 K, respectively. The dehydration/hydration cycle is reversible and the fully hydrated phase of 1(H(2)O) may be recovered on exposure to water vapour. This magnetic behaviour is in contrast to that observed in the related compound [Fe(2)(L)(3)](ClO(4))(4)·2MeCN, 1(MeCN), whereby fully reversible SCO was observed at each Fe(II) centre to give [LS:LS] species at low temperature and [HS:HS] species at higher temperatures. Reasons for this differing behaviour between 1(H(2)O) and 1(MeCN) are discussed.
Chemistry: A European Journal | 2013
Rana A. Bilbeisi; Salvatore Zarra; Humphrey L. C. Feltham; Guy N. L. Jameson; Jack K. Clegg; Sally Brooker; Jonathan R. Nitschke
How much should we switch? Two FeII₄L₄ tetrahedral capsules were shown to undergo thermally induced spin crossover (SCO). Guest binding to one of these capsules was observed to affect the thermodynamics of its SCO in solution, leading to different spin transition temperatures between the empty host (blue) and the host-guest complex (red). HS: high spin; LS: low spin.
Journal of Materials Science | 2013
Patrick N. Lemougna; Kenneth J.D. MacKenzie; Guy N. L. Jameson; Hubert Rahier; U. Chinje Melo
The behavior of the iron present in two volcanic ashes was investigated during geopolymer synthesis using sodium hydroxide as the sole alkali activator. XRD, SEM, and room-temperature 57Fe Mössbauer spectroscopy were used to monitor the behavior of the iron during the synthesis reaction. Geopolymers with very good compressive strengths were formed, especially with the finer ash, in which the iron is present in the crystalline minerals ferroan forsterite and augite. Mössbauer spectroscopy identified the ferrous sites in these minerals, plus a ferric site, probably located in an X-ray amorphous phase. The ferroan forsterite in the original ashes did not react with NaOH, but a substantial proportion of the augite reacted to form new ferric sites with parameters similar to distorted tetrahedral or 5-coordinated environments, suggesting the possible incorporation of ferric iron in the tetrahedral network of the geopolymer product. These results indicate that iron is not necessarily deleterious to geopolymer formation, as has sometimes been suggested.
Collaboration
Dive into the Guy N. L. Jameson's collaboration.
MacDiarmid Institute for Advanced Materials and Nanotechnology
View shared research outputsMacDiarmid Institute for Advanced Materials and Nanotechnology
View shared research outputs